Cryo-Cell International Inc
AMEX:CCEL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cryo-Cell International Inc
AMEX:CCEL
|
US |
|
A
|
Agrana Beteiligungs AG
VSE:AGR
|
AT |
|
Rubis SCA
LSE:0RTS
|
FR |
|
B
|
Beacon Minerals Ltd
ASX:BCN
|
AU |
|
E
|
E for L Aim PCL
SET:EFORL
|
TH |
|
C
|
Concentra Group Holdings Parent Inc
NYSE:CON
|
US |
|
Utah Medical Products Inc
NASDAQ:UTMD
|
US |
|
Petards Group PLC
LSE:PEG
|
UK |
|
Nordic Mining ASA
OSE:NOM
|
NO |
|
F5 Inc
NASDAQ:FFIV
|
US |
|
Parex Resources Inc
TSX:PXT
|
CA |
|
Renegade Exploration Ltd
ASX:RNX
|
AU |
|
North American Construction Group Ltd
TSX:NOA
|
CA |
|
A
|
Aurizon Holdings Ltd
F:QRL
|
AU |
|
P
|
Pure Hydrogen Corporation Ltd
ASX:PH2
|
US |
|
M
|
Millrose Properties Inc
NYSE:MRP
|
US |
|
C
|
Compass Group PLC
OTC:CMPGF
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CCEL's stock price target?
Not Available
CCEL doesn't have any price targets made by Wall Street professionals.
What is Cryo-Cell International Inc's Revenue forecast?
Projected CAGR
-2%
For the last 13 years the compound annual growth rate for Cryo-Cell International Inc's revenue is 5%. The projected CAGR for the next 2 years is -2%.
What is Cryo-Cell International Inc's Operating Income forecast?
Projected CAGR
-14%
For the last 13 years the compound annual growth rate for Cryo-Cell International Inc's operating income is 16%. The projected CAGR for the next 2 years is -14%.